Animal Models of Diabetic Neuropathy: Progress Since 1960s

Diabetic or peripheral diabetic neuropathy (PDN) is one of the major complications among some other diabetic complications such as diabetic nephropathy, diabetic retinopathy, and diabetic cardiomyopathy. The use of animal models in the research of diabetes and diabetic complications is very common w...

Full description

Saved in:
Bibliographic Details
Main Author: Md. Shahidul Islam
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2013/149452
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566542382923776
author Md. Shahidul Islam
author_facet Md. Shahidul Islam
author_sort Md. Shahidul Islam
collection DOAJ
description Diabetic or peripheral diabetic neuropathy (PDN) is one of the major complications among some other diabetic complications such as diabetic nephropathy, diabetic retinopathy, and diabetic cardiomyopathy. The use of animal models in the research of diabetes and diabetic complications is very common when rats and mice are most commonly used for many reasons. A numbers of animal models of diabetic and PDN have been developed in the last several decades such as streptozotocin-induced diabetic rat models, conventional or genetically modified or high-fat diet-fed C57BL/Ks (db/db) mice models, streptozotocin-induced C57BL6/J and ddY mice models, Chinese hamster neuropathic model, rhesus monkey PDN model, spontaneously diabetic WBN/Kob rat model, L-fucose-induced neropathic rat model, partial sciatic nerve ligated rat model, nonobese diabetic (NOD) mice model, spontaneously induced Ins2 Akita mice model, leptin-deficient (ob/ob) mice model, Otsuka Long-Evans Tokushima Fatty (OLETF) rat model, surgically-induced neuropathic model, and genetically modified Spontaneously Diabetic Torii (SDT) rat model, none of which are without limitations. An animal model of diabetic or PDN should mimic the all major pathogeneses of human diabetic neuropathy. Hence, this review comparatively evaluates the animal models of diabetic and PDN which are developed since 1960s with their advantages and disadvantages to help diabetic research groups in order to more accurately choose an appropriate model to meet their specific research objectives.
format Article
id doaj-art-6b6521b38f864fb7b67cee8d88eff421
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-6b6521b38f864fb7b67cee8d88eff4212025-02-03T01:03:47ZengWileyJournal of Diabetes Research2314-67452314-67532013-01-01201310.1155/2013/149452149452Animal Models of Diabetic Neuropathy: Progress Since 1960sMd. Shahidul Islam0Department of Biochemistry, School of Life Sciences, University of KwaZulu-Natal (Westville Campus), Durban 4000, South AfricaDiabetic or peripheral diabetic neuropathy (PDN) is one of the major complications among some other diabetic complications such as diabetic nephropathy, diabetic retinopathy, and diabetic cardiomyopathy. The use of animal models in the research of diabetes and diabetic complications is very common when rats and mice are most commonly used for many reasons. A numbers of animal models of diabetic and PDN have been developed in the last several decades such as streptozotocin-induced diabetic rat models, conventional or genetically modified or high-fat diet-fed C57BL/Ks (db/db) mice models, streptozotocin-induced C57BL6/J and ddY mice models, Chinese hamster neuropathic model, rhesus monkey PDN model, spontaneously diabetic WBN/Kob rat model, L-fucose-induced neropathic rat model, partial sciatic nerve ligated rat model, nonobese diabetic (NOD) mice model, spontaneously induced Ins2 Akita mice model, leptin-deficient (ob/ob) mice model, Otsuka Long-Evans Tokushima Fatty (OLETF) rat model, surgically-induced neuropathic model, and genetically modified Spontaneously Diabetic Torii (SDT) rat model, none of which are without limitations. An animal model of diabetic or PDN should mimic the all major pathogeneses of human diabetic neuropathy. Hence, this review comparatively evaluates the animal models of diabetic and PDN which are developed since 1960s with their advantages and disadvantages to help diabetic research groups in order to more accurately choose an appropriate model to meet their specific research objectives.http://dx.doi.org/10.1155/2013/149452
spellingShingle Md. Shahidul Islam
Animal Models of Diabetic Neuropathy: Progress Since 1960s
Journal of Diabetes Research
title Animal Models of Diabetic Neuropathy: Progress Since 1960s
title_full Animal Models of Diabetic Neuropathy: Progress Since 1960s
title_fullStr Animal Models of Diabetic Neuropathy: Progress Since 1960s
title_full_unstemmed Animal Models of Diabetic Neuropathy: Progress Since 1960s
title_short Animal Models of Diabetic Neuropathy: Progress Since 1960s
title_sort animal models of diabetic neuropathy progress since 1960s
url http://dx.doi.org/10.1155/2013/149452
work_keys_str_mv AT mdshahidulislam animalmodelsofdiabeticneuropathyprogresssince1960s